Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis
Authors:
- Aurélien ViaccozAVAurélien Viaccoz
- Virginie DesestretVDVirginie Desestret
- François DucrayFDFrançois Ducray
- Géraldine PicardGPGéraldine Picard
- Gaëlle CavillonGCGaëlle Cavillon
- Véronique RogemondVRVéronique Rogemond
- Jean-Christophe AntoineJAJean-Christophe Antoine
- Jean-Yves DelattreJDJean-Yves Delattre
- Jérôme HonnoratJHJérôme Honnorat
- 18 February 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 82 (7) , 556-563
Abstract
Objective: The aim of this study was to describe the clinical features and specificities of adult male patients with NMDA receptor antibodies (NMDAr-Abs) encephalitis. Methods: Observational study of 13 adult male patients who were diagnosed with NMDAr-Abs encephalitis at the French Paraneoplastic Neurological Syndrome Reference Center. Results: Adult male patients frequently presented initially with a seizure (8/13, 61.5%). Seizures were partial in 5/8 patients and were followed only a few days later (median 12 days; range 2–17 days) by psychiatric or cognitive symptoms. Conversely, adult female patients rarely presented with a seizure initially (8/58, 14%, p < 0.001), and most of their seizures were generalized and were rapidly followed (median 2 days; range 1–7 days) by behavioral and psychiatric features. Additionally, in male patients the disease was rarely associated with a tumor (1/13 or 8%, a perineal schwannoma); in contrast, 41% of female patients had an associated tumor (95% of which were ovarian teratomas; p = 0.02 male vs female association with tumor). The incidences of abnormalities in ancillary tests, treatment modalities, clinical evolution, and outcome were equal for both subgroups. Conclusion: Adult male patients who have partial seizures, normal MRI results, and no clear etiology should be tested for NMDAr-Abs to avoid any delays in treatment initiation. Adult female patients who had a seizure as the first symptom are infrequent when NMDAr-Abs encephalitis is diagnosed; additionally, their clinical pattern is different from male patients, with more generalized seizures and rapid development of behavioral and psychiatric symptoms. The differences in hormonal influence could contribute to this difference in clinical pattern.Keywords
This publication has 38 references indexed in Scilit:
- Anti-NMDA-Receptor Encephalitis: Case Report and Literature Review of an Under-Recognized ConditionJournal of General Internal Medicine, 2011
- Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisThe Lancet Neurology, 2011
- N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexesBrain, 2010
- Hormonal Aspects of EpilepsyNeurologic Clinics, 2009
- Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009
- Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratomaActa Neuropathologica, 2009
- Neurosteroid Replacement Therapy for Catamenial EpilepsyNeurotherapeutics, 2009
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008
- Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratomaAnnals of Neurology, 2007
- The Influence of Gonadal Hormones on Neuronal Excitability, Seizures, and Epilepsy in the FemaleEpilepsia, 2006